ACTIVE

FUJIREBIO EUROPE

Export PDF

Financial year 2026 · closed on 31/03/2026

Net result

-2,7 M €

-152.5% YoY

Revenue

51,4 M €

+28.1% YoY

Equity

45,7 M €

-5.6% YoY

Workforce

141,0 ETP

+0.4% YoY

What does FUJIREBIO EUROPE do?

FUJIREBIO EUROPE is a Public limited company incorporated in 1985. Its main activity is: Manufacture of other chemical products n.e.c.. Its registered office is in Gent. It employs on average 141,0 ETP workers (FTE).

Legal situation

● Normal situation

BCE/KBO no. / VAT

BE 0427.550.660

Incorporation

18/07/1985

Legal form

Public limited company

Registered office

Technologiepark-Zwijnaarde 6
9052 Gent · FlandreSee on map

Contributed capital

31 398 322,00 €

Latest accounts

31/03/2026

Average workforce

141,0 ETP

Activities (NACE)

20590Manufacture of other chemical products n.e.c.· main 20590Manufacture of other chemical products n.e.c.24660Manufacture of basic metals 72101Research and experimental development on natural sciences and engineering 72110Research and experimental development on biotechnology

Joint committees (4)

Signals

Solid equityPositive EBITDAHealthy social debtsHigh revenue

View the BCE/KBO Public Search record →

Health score

Available with a Rovalta subscriptionTry for 7 days

Recommended credit limit

✦ Verdict · Analyst summary

Financials

Trend over 17 financial years

	2026		2025		2024		2023		2022		2021		2020		2019		2018		2017		2016		2015		2014		2013		2012		2011		2007
Income statement
Revenue	51,4 M €	+28.1%	40,1 M €	+18.1%	34,0 M €	+2.1%	33,3 M €	-27.6%	45,9 M €	-8.3%	50,1 M €	+66.1%	30,2 M €	+8.3%	27,9 M €	-12.7%	31,9 M €	+13.3%	28,2 M €	-16.4%	33,7 M €	+0.0%	33,7 M €	-2.5%	34,6 M €	-2.8%	35,6 M €	-5.4%	37,6 M €	-22.1%	48,3 M €	+29.9%	37,1 M €
EBITDA	15,0 M €	+91.3%	7,8 M €	+195%	2,7 M €	+1657%	151,2 k €	-98.1%	7,9 M €	-4.5%	8,3 M €	+4565%	177,0 k €	-81.0%	934,0 k €	-89.0%	8,5 M €	+4.8%	8,1 M €	-40.3%	13,6 M €	+122%	6,1 M €	-15.0%	7,2 M €	-21.2%	9,2 M €	+36.9%	6,7 M €	+1911%	333,4 k €	-51.5%	686,6 k €
Operating result	12,6 M €	+71.4%	7,3 M €	+1957%	-395,6 k €	+65.2%	-1,1 M €	-118%	6,4 M €	+40.7%	4,5 M €	+368%	-1,7 M €	-41.3%	-1,2 M €	-118%	6,6 M €	+17.1%	5,7 M €	-50.0%	11,3 M €	+205%	3,7 M €	+7.0%	3,5 M €	-36.3%	5,4 M €	+5.9%	5,1 M €	+204%	-4,9 M €	+57.9%	-11,7 M €
Net result	-2,7 M €	-153%	5,2 M €	+1015%	-567,1 k €	+68.6%	-1,8 M €	-131%	5,9 M €	+41.4%	4,2 M €	+342%	-1,7 M €	-509%	-283,5 k €	-105%	6,1 M €	+7.4%	5,7 M €	-49.8%	11,4 M €	+131%	4,9 M €	+24.5%	4,0 M €	-35.6%	6,2 M €	-6.0%	6,5 M €	+182%	-8,0 M €	+52.5%	-16,9 M €
Balance sheet
Equity	45,7 M €	-5.6%	48,4 M €	+12.0%	43,3 M €	+27.9%	33,8 M €	-5.1%	35,6 M €	+16.9%	30,5 M €	+15.9%	26,3 M €	-6.2%	28,0 M €	-60.7%	71,3 M €	+9.4%	65,2 M €	+0.5%	64,9 M €	+21.3%	53,5 M €	+10.0%	48,6 M €	+8.6%	44,8 M €	+15.6%	38,7 M €	+19.9%	32,3 M €	+66.1%	19,4 M €
Total assets	81,8 M €	-8.6%	89,5 M €	+2.0%	87,8 M €	+0.9%	87,0 M €	+83.9%	47,3 M €	+3.4%	45,8 M €	+30.7%	35,0 M €	-7.5%	37,9 M €	-53.6%	81,6 M €	+1.6%	80,4 M €	+6.6%	75,4 M €	+20.9%	62,3 M €	+7.5%	58,0 M €	+3.1%	56,3 M €	-3.6%	58,4 M €	+3.5%	56,4 M €	-38.8%	92,1 M €
Cash	3,4 M €	+4.5%	3,3 M €	-6.7%	3,5 M €	+1.6%	3,5 M €	-8.8%	3,8 M €	+1.1%	3,8 M €	+31.8%	2,9 M €	-58.0%	6,8 M €	+4.9%	6,5 M €	-15.3%	7,7 M €	-10.4%	8,6 M €	-11.3%	9,7 M €	+35.4%	7,1 M €	+24.5%	5,7 M €	-20.2%	7,2 M €	+187%	2,5 M €	+1.1%	2,5 M €
Debts	36,0 M €	-11.6%	40,7 M €	-8.3%	44,4 M €	-15.8%	52,8 M €	+369%	11,3 M €	-26.0%	15,2 M €	+75.6%	8,7 M €	-11.2%	9,7 M €	-4.0%	10,2 M €	-32.3%	15,0 M €	+49.5%	10,0 M €	+22.9%	8,2 M €	-5.8%	8,7 M €	-13.6%	10,0 M €	-40.9%	17,0 M €	-10.8%	19,0 M €	-70.9%	65,3 M €
Other
Workforce	141,0 ETP	+0.4%	140,4 ETP	+4.3%	134,6 ETP	+4.7%	128,6 ETP	-2.7%	132,2 ETP	+6.6%	124,0 ETP	+0.9%	122,9 ETP	+2.2%	120,2 ETP	+1.2%	118,8 ETP	-6.0%	126,4 ETP	-4.7%	132,7 ETP	-8.5%	145,0 ETP	-21.2%	184,0 ETP	-2.7%	189,2 ETP	-4.5%	198,1 ETP	-22.3%	254,8 ETP	-28.0%	353,8 ETP

Estimate

Indicative valuation

As an indication, this company is worth

between 25 M€ and 50 M€

See the valuation

Governance

Board of directors

Seen on filing of 31/03/2026 · 5 active · 75 ended

Active mandates

TADASHI NINOMIYA

Director · since 01 avril 2026 · until 19 juin 2026

Active

AOKI KOJI

Director · since 17 juin 2022 · until 19 juin 2026

Active

CDW INVEST

Managing director · since 17 juin 2022 · until 19 juin 2026 · 0883.186.483

Represented by Christiaan De Wilde

Active

KURT TROCH

Director · since 17 juin 2022 · until 19 juin 2026

Active

GOKI ISHIKAWA

Director · since 25 juin 2014 · until 01 avril 2026

Active

Ended mandates

AOKI KOJI

Director · since 17 juin 2022 · until 16 juin 2023

Ended

AOKI KOJI

Director · since 17 juin 2022 · until 21 juin 2024

Ended

AOKI KOJI

Director · since 17 juin 2022 · until 20 juin 2025

Ended

CDW INVEST

Managing director · since 17 juin 2022 · until 16 juin 2023 · 0883.186.483

Represented by Christiaan De Wilde

Ended

At this address

Other companies at this address

Company	CBE no.
ADx NeuroSciences● Active	0839.400.980
FujiADx● Active	1004.979.782

Annual accounts

Full financial information

	2026	2025	2024	2023	2022	2021
Type of account	Full model	Full model	Full model	Full model	m120-f-p	Full model
Start of the financial year	01/04/2025	01/04/2024	01/04/2023	01/04/2022	01/04/2021	01/04/2020
Closing of the financial year	31/03/2026	31/03/2025	31/03/2024	31/03/2023	31/03/2022	31/03/2021
Length of the financial year	12 months	12 months	12 months	12 months	12 months	12 months
Filing date	24/06/2026	07/07/2025	04/07/2024	19/06/2023	19/07/2022	22/06/2021
General meeting	19/06/2026	20/06/2025	21/06/2024	16/06/2023	21/06/2022	18/06/2021
Currency of the financial year	EUR	EUR	EUR	EUR	JPY	EUR
NBB quality label	Satisfying controls	Satisfying controls	Satisfying controls	Satisfying controls	Satisfying controls	Satisfying controls

Ratios

Financial ratios

Looking for more information about this company?

Try for 7 days

Filings

Annual accounts filings

28 filings with the NBB

Model	Closing	General meeting	Filed	Language	Document
Full model	31/03/2026	19/06/2026	24/06/2026	Dutch	PDF
m120-f-p	31/03/2026	16/06/2026	24/06/2026	English	PDF
Full model	31/03/2025	20/06/2025	07/07/2025	Dutch	PDF
m121-f-p	31/03/2025	17/06/2025	23/07/2025	English	PDF
Full model	31/03/2024	21/06/2024	04/07/2024	Dutch	PDF
m121-f-p	31/03/2024	18/06/2024	17/07/2024	English	PDF
Full model	31/03/2023	16/06/2023	19/06/2023	Dutch	PDF
m120-f-p	31/03/2023	20/06/2023	04/08/2023	English	PDF
Full model	31/03/2022	17/06/2022	24/06/2022	Dutch	PDF
m120-f-p	31/03/2022	21/06/2022	19/07/2022	Dutch	PDF
Full model	31/03/2021	18/06/2021	22/06/2021	Dutch	PDF
Full model	31/03/2020	19/06/2020	06/07/2020	Dutch	PDF
Full model	31/03/2019	21/06/2019	08/07/2019	Dutch	PDF
Full model	31/03/2018	15/06/2018	05/07/2018	Dutch	PDF
Full model	31/03/2017	16/06/2017	22/06/2017	Dutch	PDF
Full model	31/03/2016	17/06/2016	01/07/2016	Dutch	PDF
Full model	31/03/2015	19/06/2015	14/07/2015	Dutch	PDF
Full model	31/03/2014	25/06/2014	17/07/2014	Dutch	PDF
Full model	31/03/2013	19/06/2013	15/07/2013	Dutch	PDF
Full model	31/03/2012	19/06/2012	30/07/2012	Dutch	PDF
Full model	31/03/2011	17/06/2011	01/07/2011	Dutch	PDF
Full modelCorrection	31/12/2009	30/08/2010	04/03/2011	Dutch	PDF
Full model	31/12/2009	30/06/2010	11/08/2010	Dutch	PDF
Full model	31/12/2008	27/03/2009	14/07/2009	Dutch	PDF

View all 28 filings

Estimate

Indicative valuation

Order of magnitude

As an indication, this company is worth

between 25 M€ and 50 M€

The detail comes with the Business plan: low and high bounds, the valuation bridge for each financial year, transaction multiples by sector and size, group valuation and exports.

Discover the Business plan

Disclaimer

Indicative estimate based on public sector multiples and the filed annual accounts. It is neither a certified valuation nor financial or investment advice.

Governance

Board of directors

Seen on filing of 31/03/2026 · 5 active · 75 ended

Active mandates

TADASHI NINOMIYA

Director · since 01 avril 2026 · until 19 juin 2026

Active

AOKI KOJI

Director · since 17 juin 2022 · until 19 juin 2026

Active

CDW INVEST

Managing director · since 17 juin 2022 · until 19 juin 2026 · 0883.186.483

Represented by Christiaan De Wilde

Active

KURT TROCH

Director · since 17 juin 2022 · until 19 juin 2026

Active

GOKI ISHIKAWA

Director · since 25 juin 2014 · until 01 avril 2026

Active

Ended mandates

AOKI KOJI

Director · since 17 juin 2022 · until 16 juin 2023

Ended

AOKI KOJI

Director · since 17 juin 2022 · until 21 juin 2024

Ended

AOKI KOJI

Director · since 17 juin 2022 · until 20 juin 2025

Ended

CDW INVEST

Managing director · since 17 juin 2022 · until 16 juin 2023 · 0883.186.483

Represented by Christiaan De Wilde

Ended

Shareholders

Ownership and network

Looking for more information about this company?

Try for 7 days

Belgian Official Gazette

Belgian Official Gazette publications

Restructuring08/05/2026
DOEL - KAPITAAL - AANDELEN - RUBRIEK HERSTRUCTURERING (FUSIE, SPLITSING, OVERDRACHT VERMOGEN, ENZ...)
PDF
Mandates04/05/2026
ONTSLAGEN - BENOEMINGEN
PDF
Restructuring19/02/2026
KAPITAAL - AANDELEN - RUBRIEK HERSTRUCTURERING (FUSIE, SPLITSING, OVERDRACHT VERMOGEN, ENZ...)
PDF
Mandates14/10/2025
ONTSLAGEN - BENOEMINGEN
PDF
Mandates03/10/2024
ONTSLAGEN - BENOEMINGEN
PDF
Capital / shares12/01/2024
STATUTEN (VERTALING, COÖRDINATIE, OVERIGE WIJZIGINGEN, ) - KAPITAAL - AANDELEN
PDF
Mandates04/09/2023
ONTSLAGEN - BENOEMINGEN
PDF
Mandates19/09/2022
ONTSLAGEN - BENOEMINGEN
PDF

Source: Belgian Official Gazette

Competition

Similar companies

A company's peers, by sector and size, are included in the Business plan.

See the Business plan

01/04/2026
autre
01/04/2026
nominationTadashi Ninomiya — Bestuurder
2026
Annual accounts 2026-2,7 M €↓
20/06/2025
reconductionGoki Ishikawa — lid van de Raad van Bestuur
20/06/2025
reconductionKoji Aoki — lid van de Raad van Bestuur
20/06/2025
reconductionKurt Troch — lid van de Raad van Bestuur
2025
Annual accounts 20255,2 M €↑
21/06/2024
reconductionGoki Ishikawa — leden van de Raad van Bestuur
21/06/2024
reconductionKoji Aoki — leden van de Raad van Bestuur
21/06/2024
reconductionKurt Troch — leden van de Raad van Bestuur
21/06/2024
nominationWouter Coppens — commissaris
2024
Annual accounts 2024-567,1 k €↑
16/06/2023
reconductionGoki Ishikawa — leden van de Raad van Bestuur
16/06/2023
reconductionKurt Troch — leden van de Raad van Bestuur
2023
Annual accounts 2023-1,8 M €↓
23/07/2022
autre
17/06/2022
nominationGoki Ishikawa — lid van de Raad van Bestuur
17/06/2022
nominationKoji Aoki — lid van de Raad van Bestuur
17/06/2022
nominationCDW Invest BV — lid van de Raad van Bestuur
17/06/2022
nominationKurt Troch — lid van de Raad van Bestuur
2022
Annual accounts 20225,9 M €↑
2021
Annual accounts 20214,2 M €↑
2020
Annual accounts 2020-1,7 M €↓
2019
Annual accounts 2019-283,5 k €↓
2018
Annual accounts 20186,1 M €↑
2017
Annual accounts 20175,7 M €↓
2016
Annual accounts 201611,4 M €↑
2015
Annual accounts 20154,9 M €↑
2014
Annual accounts 20144,0 M €↓
2014
Name changeFujirebio Europe nv
2013
Annual accounts 20136,2 M €↓
2012
Annual accounts 20126,5 M €↑
2011
Annual accounts 2011-8,0 M €↑
2007
Annual accounts 2007-16,9 M €
2007
Name changeINNOGENETICS
18/07/1985
IncorporationPublic limited company

10/15	1 240 000	1 180 000	1 050 000
70	8 630 000	8 120 000	7 940 000
9904	412 000	388 000	301 000
17/49	2 970 000	3 140 000	3 380 000
9087	24,3	23,1	21,8

FUJIREBIO EUROPE

Overview

What does FUJIREBIO EUROPE do?

Trend over 17 financial years

Indicative valuation

Board of directors

Other companies at this address

Financials

Full financial information

Financial ratios

Annual accounts filings

Valuation

Indicative valuation

Directors & structure

Board of directors

Ownership and network

Publications

Belgian Official Gazette publications

Similar companies

Similar companies

Timeline